Sanders Vows to Block Health Nominees Until Biden Releases “Clear Strategy” to Lower Prescription Drug Prices

The report found that nearly every drug that’s been created with the aid of taxpayer-funded NIH research is more expensive for Americans than for people in other countries, with pharmaceutical companies using research from the NIH, which can come in at nearly every step of the drug development process, to create and commercialize new drugs.

The report highlights some of the most absurd differences between U.S. and other comparably wealthy countries’ prices for drugs, despite those drugs being developed using U.S. taxpayer money. Gilead Sciences’s cancer drug Yescarta costs $212,000 in Japan, but costs double the price, $424,000, in the U.S. Another drug, a hormone therapy drug called Myalept, costs $580,000 a year in France — and $1.9 million a year in the U.S. Even cheaper drugs cost more in the U.S.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Sanders vows to oppose NIH nominee until Biden produces drug-pricing planSen. Bernie Sanders (I-Vt.), chair of the Senate health panel, is vowing to not move forward with President Biden’s nominee to lead the National Institutes of Health until he receives the administration’s “comprehensive” plan on lowering drug prices.
Source: washingtonpost - 🏆 95. / 72 Read more »

The Importance of Women’s Health and Mental Health, with Beth Battaglino | Women@WorkOur CEO BBCRN joined LauraZarrow on SXMBusiness to talk about the importance of women’s health and mental health.
Source: HealthyWomen - 🏆 29. / 68 Read more »

Bernie Sanders to block all Biden health nominees until admin delivers plan to lower drug prices: ReportSen. Bernie Sanders, I-Vt., has vowed not to block President Biden's health nominees until his administration delivers a plan to lower drug prices.
Source: FoxNews - 🏆 9. / 87 Read more »